GlassScriptPhysician profile
Noor Salam
NPI 1285015123
$8,161.92
in general payments reported to CMS, 2019-2025
25 companies · $5,574 in 2025
The $5,574 reported for 2025 was more than what 98% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $60.67 · 2020: $63.44 · 2021: $145 · 2022: $947 · 2023: $779 · 2024: $593 · 2025: $5,574.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,087 · Food and Beverage: $1,829 · Travel and Lodging: $1,031.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,086.66 |
| Food and Beverage | $1,828.64 |
| Travel and Lodging | $1,030.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,146.28 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $424.01 | 2021-2025 | Fasenra, Airsupra, Breztri |
| Glaxosmithkline, LLC. | $405.44 | 2020-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Regeneron Healthcare Solutions, INC. | $403.64 | 2022-2024 | Dupixent |
| Boehringer Ingelheim Pharmaceuticals, INC. | $355.60 | 2019-2025 | Ofev |
| Inari Medical, INC. | $335.54 | 2022-2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Ambu INC. | $241.28 | 2022-2023 | |
| Philips North America LLC | $217.52 | 2022-2025 | Vest Therapy Und, (Ak6) Vest Therapy |
| Amgen INC. | $97.18 | 2023-2025 | Tezspire |
| Mylan Specialty L.P. | $93.40 | 2022-2024 | Yupelri |
| United Therapeutics Corporation | $66.40 | 2023-2025 | Tyvaso, Tyvaso, Orenitram |
| Inspire Medical Systems, INC. | $48.51 | 2023-2024 | Inspire |
| Genzyme Corporation | $46.94 | 2022-2024 | |
| Boston Scientific Corporation | $36.33 | 2022 | |
| Insmed, INC. | $34.28 | 2025 | Arikayce |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vifor Pharma, INC. | $33.92 | 2022-2023 | Veltassa |
| Pfizer INC. | $31.23 | 2022-2023 | |
| Getinge USA Sales, LLC | $31.14 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $22.95 | 2025 | Hyqvia |
| Jazz Pharmaceuticals INC. | $18.96 | 2024 | |
| Harmony Biosciences LLC | $15.06 | 2024 | |
| Circassia INC. | $14.87 | 2019 | |
| Viatris Specialty LLC | $13.96 | 2025 | Yupelri |
| Mallinckrodt Hospital Products INC. | $13.76 | 2022 | |
| Verona Pharma, INC. | $13.72 | 2025 | Ohtuvayre |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Noor Salam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.